Jean-Charles Soria/LinkedIn
Jun 2, 2025, 14:49
Jean-Charles Soria: Carcinoma of Unknown Primary
Jean-Charles Soria, Amgen’s senior vice president of Oncology within Global Development, shared an article on LinkedIn:
“Carcinoma of Unknown Primary: Cancer without a past.
- Early dissemination.
- Immune editing of the primary.
- CK20+, CDX2+, SATB2+ → treat colon-like.
Let biology, not anatomy, guide therapy.
Not a diagnostic failure — a metastatic strategy.”
Cancer of Unknown Primary Site.
Authors: Kanwal Raghav.
You can read the full article on The New England Journal of Medicine.
More posts featuring Jean-Charles Soria.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 01:58
Jun 4, 2025, 00:35